Page last updated: 2024-09-05

sb 203580 and temocapril hydrochloride

sb 203580 has been researched along with temocapril hydrochloride in 1 studies

Compound Research Comparison

Studies
(sb 203580)
Trials
(sb 203580)
Recent Studies (post-2010)
(sb 203580)
Studies
(temocapril hydrochloride)
Trials
(temocapril hydrochloride)
Recent Studies (post-2010) (temocapril hydrochloride)
3,48941,1371543215

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Akishita, M; Hasegawa, H; Kozaki, K; Nagai, K; Sudoh, N; Toba, K; Xi, H; Yu, W1

Other Studies

1 other study(ies) available for sb 203580 and temocapril hydrochloride

ArticleYear
Angiotensin converting enzyme inhibitor attenuates oxidative stress-induced endothelial cell apoptosis via p38 MAP kinase inhibition.
    Clinica chimica acta; international journal of clinical chemistry, 2006, Volume: 364, Issue:1-2

    Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Apoptosis; Cattle; Cells, Cultured; DNA Fragmentation; Dose-Response Relationship, Drug; Endothelial Cells; Enzyme Inhibitors; Hydrogen Peroxide; Imidazoles; Oxidative Stress; p38 Mitogen-Activated Protein Kinases; Pyridines; Thiazepines; Tumor Necrosis Factor-alpha

2006